• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimizing thiopurine dosing based on TPMT and NUDT15 genotypes: It takes two to tango.

作者信息

Koutsilieri Stefania, Caudle Kelly E, Alzghari Saeed Khaled, Monte Andrew A, Relling Mary V, Patrinos George P

机构信息

Department of Pharmacy, University of Patras School of Health Sciences, Patras, Greece.

Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.

出版信息

Am J Hematol. 2019 Jul;94(7):737-740. doi: 10.1002/ajh.25485. Epub 2019 Apr 10.

DOI:10.1002/ajh.25485
PMID:30945335
Abstract
摘要

相似文献

1
Optimizing thiopurine dosing based on TPMT and NUDT15 genotypes: It takes two to tango.基于硫嘌呤甲基转移酶（TPMT）和NUDT15基因分型优化硫嘌呤给药：两人才能跳探戈。
Am J Hematol. 2019 Jul;94(7):737-740. doi: 10.1002/ajh.25485. Epub 2019 Apr 10.
2
Personalization of thiopurine therapy: Current recommendations and future perspectives.硫唑嘌呤治疗的个体化：当前建议和未来展望。
Acta Pharm. 2024 Sep 14;74(3):355-381. doi: 10.2478/acph-2024-0030. Print 2024 Sep 1.
3
NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.NUDT15和TPMT基因多态性与黎巴嫩儿童癌症中心接受急性淋巴细胞白血病治疗的儿童对6-巯基嘌呤不耐受有关。
Pediatr Blood Cancer. 2017 Jan;64(1):146-150. doi: 10.1002/pbc.26189. Epub 2016 Aug 31.
4
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.基于 TPMT 和 NUDT15 基因型的硫嘌呤药物剂量调整：临床药物遗传学实施联盟指南 2018 年更新版。
Clin Pharmacol Ther. 2019 May;105(5):1095-1105. doi: 10.1002/cpt.1304. Epub 2019 Jan 20.
5
Influence of TPMT and NUDT15 Genetic Polymorphisms on Mercaptopurine Pharmacokinetics in Healthy Volunteers.TPMT 和 NUDT15 基因多态性对健康志愿者巯嘌呤药代动力学的影响。
Genet Test Mol Biomarkers. 2024 Aug;28(8):322-327. doi: 10.1089/gtmb.2023.0605. Epub 2024 Jul 31.
6
Thiopurine treatment in childhood leukemia. Metabolic aspects and sensitivity.
Adv Exp Med Biol. 1998;431:687-92. doi: 10.1007/978-1-4615-5381-6_133.
7
DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes.DNA-硫鸟嘌呤核苷酸作为 NUDT15 变异基因型急性淋巴细胞白血病患者的治疗标志物。
PLoS One. 2021 Jan 22;16(1):e0245667. doi: 10.1371/journal.pone.0245667. eCollection 2021.
8
The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia.巯嘌呤治疗瑞典儿童急性淋巴细胞白血病患者时 TPMT、ITPA 和 NUDT15 变异体的作用。
J Pediatr. 2020 Jan;216:150-157.e1. doi: 10.1016/j.jpeds.2019.09.024. Epub 2019 Oct 18.
9
Preclinical evaluation of -guided thiopurine therapy and its effects on toxicity and antileukemic efficacy.- 指导下的硫唑嘌呤治疗的临床前评估及其对毒性和抗白血病疗效的影响。
Blood. 2018 May 31;131(22):2466-2474. doi: 10.1182/blood-2017-11-815506. Epub 2018 Mar 23.
10
TPMT and NUDT15 genes are both related to mercaptopurine intolerance in acute lymphoblastic leukaemia patients from Uruguay.TPMT和NUDT15基因均与乌拉圭急性淋巴细胞白血病患者对巯嘌呤的不耐受性有关。
Br J Haematol. 2018 Apr;181(2):252-255. doi: 10.1111/bjh.14532. Epub 2017 Feb 1.

引用本文的文献

1
Clinical impact of pharmacogenetic risk variants in a large chinese cohort.中国一个大型队列中药物遗传学风险变异的临床影响
Nat Commun. 2025 Jul 9;16(1):6344. doi: 10.1038/s41467-025-61644-x.
2
Association between genetic variants of membrane transporters and the risk of high-grade hematologic adverse events in a cohort of Mexican children with B-cell acute lymphoblastic leukemia.墨西哥B细胞急性淋巴细胞白血病儿童队列中膜转运蛋白基因变异与高级别血液学不良事件风险的关联
Front Oncol. 2024 Jan 10;13:1276352. doi: 10.3389/fonc.2023.1276352. eCollection 2023.
3
Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia.
津巴布韦黑人队列中 6-巯基嘌呤治疗急性淋巴细胞白血病的药物遗传学研究。
Pharmacogenomics. 2023 Jun;24(8):449-457. doi: 10.2217/pgs-2023-0026. Epub 2023 May 30.
4
Association of ITPA gene polymorphisms with adverse effects of AZA/6-MP administration: a systematic review and meta-analysis.ITPA 基因多态性与 AZA/6-MP 治疗不良反应的关联：系统评价和荟萃分析。
Pharmacogenomics J. 2022 Feb;22(1):39-54. doi: 10.1038/s41397-021-00255-3. Epub 2022 Jan 17.
5
First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus.**阿联酋第一次炎症性肠病诊断和管理共识：2020 年德尔菲共识**
World J Gastroenterol. 2020 Nov 21;26(43):6710-6769. doi: 10.3748/wjg.v26.i43.6710.
6
Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology.药物基因组学作为限制化疗药物急性和长期不良反应的工具：儿科肿瘤学的最新进展
Front Pharmacol. 2020 Aug 5;11:1184. doi: 10.3389/fphar.2020.01184. eCollection 2020.
7
Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia.实施药物遗传学以个体化急性淋巴细胞白血病患儿的治疗方案。
Pharmgenomics Pers Med. 2020 Aug 12;13:295-317. doi: 10.2147/PGPM.S239602. eCollection 2020.
8
Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia.6-巯基嘌呤在中国儿童急性淋巴细胞白血病中的精准治疗
Br J Clin Pharmacol. 2020 Aug;86(8):1519-1527. doi: 10.1111/bcp.14258. Epub 2020 Mar 3.
9
, , and Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia.、和基因多态性预测中东急性淋巴细胞白血病儿童的6-巯基嘌呤毒性。
Front Pharmacol. 2019 Aug 27;10:916. doi: 10.3389/fphar.2019.00916. eCollection 2019.